We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FWRG icon
251
First Watch Restaurant Group
FWRG
$766M
– –
-375,000
Closed -$6.98M
GB
252
DELISTED
Global Blue Group Holding
GB
– –
-1,214,475
Closed -$8.42M
GKOS icon
253
Glaukos
GKOS
$10.6B
– –
-58,919
Closed -$8.83M
GOOS
254
Canada Goose Holdings
GOOS
$856M
– –
-215,000
Closed -$2.16M
GRPN icon
255
Groupon
GRPN
$1.02B
– –
-275,000
Closed -$3.34M
HCWB icon
256
HCW Biologics
HCWB
$5.45M
– –
-8,432
Closed -$903K
HSCSW icon
257
HeartSciences Inc Warrant
HSCSW
$71K
– –
-3,529
Closed -$106
ILMN icon
258
Illumina
ILMN
$28.4B
– –
-70,083
Closed -$9.37M
INSP icon
259
Inspire Medical Systems
INSP
$1.74B
– –
-2,500
Closed -$463K
IPAR icon
260
Interparfums
IPAR
$3.94B
– –
-24,352
Closed -$3.2M
NEXRW
261
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
– –
-5,284
Closed -$158
KTTA icon
262
Pasithea Therapeutics
KTTA
$16.9M
– –
-61,000
Closed -$192K
DFSCW
263
DEFSEC Technologies Warrant
DFSCW
– –
-12,000
Closed -$247
LEXX icon
264
Lexaria Bioscience
LEXX
$8.71M
– –
-30,667
Closed -$966K
LIVN icon
265
LivaNova
LIVN
$4.2B
– –
-53,000
Closed -$2.45M
LW icon
266
Lamb Weston
LW
$7.19B
– –
-75,733
Closed -$5.06M
MBIO icon
267
Mustang Bio
MBIO
$4.55M
– –
-72,131
Closed -$638K
MKC icon
268
McCormick & Company Non-Voting
MKC
$14.2B
– –
-263,137
Closed -$20.1M
MNST icon
269
Monster Beverage
MNST
$88.5B
– –
-569,431
Closed -$29.9M
FEED
270
ENvue Medical Inc
FEED
$3.72M
– –
-1,721
Closed -$112K
PVH icon
271
PVH
PVH
$4.04B
– –
-39,784
Closed -$4.21M
QNRX
272
Quoin Pharmaceuticals
QNRX
$9.62M
– –
-15,143
Closed -$345K
RL icon
273
Ralph Lauren
RL
$23.6B
– –
-11,656
Closed -$2.69M
RSI icon
274
Rush Street Interactive
RSI
$2.88B
– –
-275,000
Closed -$3.77M
RVPH
275
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
– –
-68,200
Closed -$2.47M
8 9 10
11
12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.